The pathophysiological understanding of atherosclerosis has evolved over the past two decades to recognize inflammation and triglyceride-rich lipoproteins as causal drivers of the disease.
Peter Libby (Tue,) conducted a editorial in Atherosclerosis. The pathophysiological understanding of atherosclerosis has evolved over the past two decades to recognize inflammation and triglyceride-rich lipoproteins as causal drivers of the disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: